ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck And Wellcome Launch Vaccine Venture

by Michael McCoy
September 21, 2009 | APPEARED IN VOLUME 87, ISSUE 38

Merck & Co. and the Wellcome Trust have created a research and development joint venture focused on affordable vaccines for poor countries. The partners will invest about $130 million over the next seven years to support a staff of 60 researchers. They say the venture marks the first time a drug company and a research charity have formed such an equally funded and separate entity. It will be based in India and called MSD Wellcome Trust Hilleman Laboratories, after pioneering vaccine scientist Maurice R. Hilleman.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment